Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
11.85
-0.10 (-0.84%)
At close: Apr 28, 2026, 4:00 PM EDT
11.88
+0.03 (0.21%)
After-hours: Apr 28, 2026, 6:37 PM EDT
Kazia Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Kazia Therapeutics stock have an average target of 19.5, with a low estimate of 15 and a high estimate of 25. The average target predicts an increase of 64.56% from the current stock price of 11.85.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +110.97% | Apr 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +51.90% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $18 | Strong Buy | Maintains | $13 → $18 | +51.90% | Dec 12, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +68.78% | Oct 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $13 | Strong Buy | Maintains | $2 → $13 | +9.70% | Jul 10, 2025 |
Financial Forecast
Revenue This Year
190.74K
from 1.83M
Decreased by -89.57%
Revenue Next Year
119.34K
from 190.74K
Decreased by -37.43%
EPS This Year
-0.69
from -18.89
EPS Next Year
-0.57
from -0.69
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 484,050 | 304,500 | ||||||
| Avg | 190,740 | 119,340 | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -73.5% | 59.6% | ||||||
| Avg | -89.6% | -37.4% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.01 | - | ||||||
| Avg | -0.69 | -0.57 | ||||||
| Low | -1.32 | -1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.